VentriPoint Diagnostics Ltd.
- Jurisdiction
Canada - ISIN
CA92281P2008 (VPT.V )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. Read full profile
Stock price
Fundamentals
- Net revenue
€101.72K - Gross margin
90.7% - EBIT
-€2.73M - EBIT margin
-2,687.7% - Net income
-€2.87M - Net margin
-2,816.9%
Statement period: - (published )
Dividends
No dividend payouts